{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:17:15Z","timestamp":1733203035704,"version":"3.30.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.anl.2020.07.002","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T15:24:44Z","timestamp":1594913084000},"page":"1189-1192","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cetuximab and paclitaxel combination therapy for recurrent basaloid squamous cell carcinoma in the ethmoid sinus"],"prefix":"10.1016","volume":"48","author":[{"given":"Satoshi","family":"Koyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taihei","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2020.07.002_bib0001","series-title":"World health organization classification of tumours. Pathology and genetics of head and neck tumours","first-page":"124","article-title":"Basaloid squamous cell carcinoma","author":"Cardesa","year":"2005"},{"key":"10.1016\/j.anl.2020.07.002_bib0002","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00005537-200009000-00013","article-title":"Basaloid squamous cell carcinoma of the head and neck","volume":"110","author":"Paulino","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2020.07.002_bib0003","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anl.2016.09.005","article-title":"Basaloid squamous cell carcinoma arising in an inverted papilloma in the nasal cavity: a case report and review","volume":"44","author":"Koyama","year":"2017","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2020.07.002_bib0004","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3748\/wjg.v13.i26.3634","article-title":"Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin","volume":"13","author":"Shibata","year":"2007","journal-title":"World Gastroenterol"},{"key":"10.1016\/j.anl.2020.07.002_bib0005","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2020.07.002_bib0006","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4132\/jptm.2017.03.03","volume":"51","author":"Cho","year":"2017","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.anl.2020.07.002_bib0007","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.23486","article-title":"Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study","volume":"112","author":"Thariat","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.anl.2020.07.002_bib0008","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/annonc\/mdr367","article-title":"The Spanish Head and Neck Cancer Cooperative Group (TTCC). Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and\/or metastatic squamous cell carcinoma of head and neck","volume":"23","author":"Hitt","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anl.2020.07.002_bib0009","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/CAD.0b013e32835507e5","article-title":"Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent\/metastatic head and neck squamous cell carcinoma","volume":"23","author":"P\u00e9ron","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.anl.2020.07.002_bib0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.oraloncology.2012.09.003","article-title":"Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent-metastatic head and neck cancer patients","volume":"49","author":"Jim\u00e9nez","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2020.07.002_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.oraloncology.2017.07.022","article-title":"A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent\/metastatic squamous cell head and neck carcinoma","volume":"73","author":"Nakano","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2020.07.002_bib0012","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1158\/1078-0432.CCR-04-0012","article-title":"Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines","volume":"10","author":"Kalish","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2020.07.002_bib0013","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1158\/1078-0432.CCR-05-2404","article-title":"Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells","volume":"12","author":"Erjala","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2020.07.002_bib0014","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1158\/1535-7163.MCT-07-0138","article-title":"Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma","volume":"6","author":"Frederick","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.anl.2020.07.002_bib0015","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1445-1433.2004.03130.x","article-title":"Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel","volume":"74","author":"Jefford","year":"2004","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.anl.2020.07.002_bib0016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.critrevonc.2014.07.005","article-title":"Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab: a systematic review and meta-analysis","volume":"93","author":"Abdel-Rahman","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.anl.2020.07.002_bib0017","doi-asserted-by":"crossref","first-page":"e55128","DOI":"10.1371\/journal.pone.0055128","article-title":"Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"10.1016\/j.anl.2020.07.002_bib0018","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.6004\/jnccn.2009.0074","article-title":"NCCN task force report: management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer","volume":"7","author":"Burtness","year":"2009","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814620301590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814620301590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T20:49:30Z","timestamp":1733172570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814620301590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0385814620301590"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2020.07.002","relation":{},"ISSN":["0385-8146"],"issn-type":[{"type":"print","value":"0385-8146"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cetuximab and paclitaxel combination therapy for recurrent basaloid squamous cell carcinoma in the ethmoid sinus","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2020.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Oto-Rhino-Laryngological Society of Japan Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}